$8.9 M

MHTX Mkt cap, 08-Oct-2018

$50 K

Manhattan Scientifics Revenue Q2, 2019
Manhattan Scientifics Net income (Q2, 2019)-908 K
Manhattan Scientifics EBIT (Q2, 2019)-490 K
Manhattan Scientifics Cash, 30-Jun-2019230 K

Manhattan Scientifics Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

652.0k64.0k150.0k142.0k

R&D expense

960.0k2.9m3.3m175.0k52.0k

General and administrative expense

1.5m3.4m3.2m2.1m1.4m

Operating expense total

2.5m6.3m6.5m2.4m1.4m

Pre tax profit

(1.9m)8.0m(6.1m)

Net Income

(1.9m)8.0m(6.1m)1.5m(8.3m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2019Q2, 2019

Revenue

17.0k180.0k150.0k158.0k4.0k1.0k107.0k42.0k41.0k59.0k50.0k

R&D expense

396.0k475.0k542.0k626.0k757.0k962.0k1.0m589.0k824.0k658.0k11.0k1.0k2.0k

General and administrative expense

2.9m860.0k649.0k300.0k1.3m1.0m813.0k1.0m698.0k776.0k367.0k317.0k220.0k538.0k

Operating expense total

2.9m1.3m1.1m842.0k1.9m1.8m1.8m2.1m1.3m1.6m(291.0k)306.0k221.0k540.0k

EBIT

(1.1m)(1.8m)(2.1m)(1.2m)(1.6m)(490.0k)

EBIT margin, %

(598%)(206000%)(1103%)(3710%)(980%)

Net Income

(2.9m)(1.1m)(1.1m)(764.0k)(2.0m)(2.1m)(1.9m)(2.1m)(1.4m)(610.0k)(436.0k)(908.0k)

Manhattan Scientifics Balance Sheet

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

578.0k5.4m1.1m269.0k87.0k

Accounts Receivable

44.0k

Current Assets

590.0k5.4m1.1m278.0k98.0k

PP&E

147.0k291.0k165.0k8.0k6.0k

Total Assets

1.9m12.9m7.6m10.8m2.7m

Accounts Payable

389.0k829.0k1.3m209.0k221.0k

Short-term debt

2.1m

Current Liabilities

1.8m1.3m1.7m1.6m1.8m

Long-term debt

1.3m

Non-Current Liabilities

1.3m1.9m2.1m

Total Debt

1.3m2.1m

Total Liabilities

3.0m3.3m3.9m1.6m1.8m

Additional Paid-in Capital

56.7m63.6m63.5m67.3m67.3m

Retained Earnings

(55.2m)(61.3m)(59.7m)(68.0m)

Total Equity

(2.2m)8.6m2.7m8.2m(150.0k)

Financial Leverage

-0.8 x1.5 x2.8 x1.3 x-17.7 x

Manhattan Scientifics Cash Flow

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.9m)8.0m(6.1m)

Depreciation and Amortization

793.0k995.0k857.0k622.0k

Accounts Receivable

(44.0k)44.0k

Accounts Payable

155.0k463.0k505.0k38.0k33.0k

Cash From Operating Activities

(964.0k)

Purchases of PP&E

(179.0k)(255.0k)(13.0k)(8.0k)

Cash From Investing Activities

(179.0k)(255.0k)(13.0k)(8.0k)500.0k

Cash From Financing Activities

1.6m(324.0k)275.0k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019Q2, 2019

Net Income

(3.4m)(1.1m)(2.2m)(2.9m)11.5m9.4m(1.9m)(4.0m)(5.3m)(436.0k)(1.3m)

Depreciation and Amortization

137.0k50.0k100.0k151.0k470.0k892.0k240.0k493.0k745.0k250.0k428.0k609.0k183.0k365.0k1.0k2.0k

Accounts Receivable

30.0k30.0k44.0k

Accounts Payable

73.0k(48.0k)57.0k(48.0k)(18.0k)339.0k157.0k388.0k730.0k237.0k(40.0k)229.0k40.0k69.0k117.0k189.0k

Cash From Operating Activities

(459.0k)(702.0k)(804.0k)(1.7m)5.9m4.5m(1.4m)(2.9m)(3.6m)(99.0k)(155.0k)

Purchases of PP&E

(179.0k)(2.0k)(19.0k)(242.0k)(255.0k)(13.0k)(13.0k)(23.0k)(23.0k)(8.0k)(2.0k)(2.0k)

Cash From Investing Activities

(179.0k)(2.0k)(19.0k)(242.0k)(255.0k)(13.0k)(13.0k)(23.0k)(8.1m)(8.0k)(2.0k)298.0k

Cash From Financing Activities

1.2m1.8m2.0m2.4m(138.0k)2.8m50.0k

Interest Paid

100.0k

Manhattan Scientifics Ratios

USDY, 2019

Revenue/Employee

50.0k

Financial Leverage

-1.7 x